Evidence map›Paper›PMID 20955776›Full record

Trial reportBrain, behavior, and immunity2011

Citalopram reduces endotoxin-induced fatigue.

Jonas Hannestad, Nicole DellaGioia, Nyrma Ortiz, Brian Pittman, Zubin Bhagwagar

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Brain, behavior, and immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pharmacological treatments for fatigue associated with palliative care.The Cochrane database of systematic reviews · 2015
    Pooled it
  2. Citalopram versus other anti-depressive agents for depression.The Cochrane database of systematic reviews · 2012
    Pooled it
  3. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2011
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Glucose metabolism in the insula and cingulate is affected by systemic inflammation in humans.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2012
    Trial
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jonas HannestadDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. jonas.hannestad@yale.edu
Nicole DellaGioia
Nyrma Ortiz
Brian Pittman
Zubin Bhagwagar
Yale University · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
NCRR NIH HHS UL1 RR024139
6 · The paper itself

Abstract

Increased levels of inflammatory cytokines such as tumor necrosis factor (TNF) and interleukin-6 (IL-6) may play a role in depression. Mild depressive-like symptoms can be induced in humans through activation of the innate immune system with endotoxin. Whether preventive treatment with antidepressants can reduce endotoxin-induced symptoms has never been tested. In a double-blind, randomized, placebo-controlled, cross-over study, we administered intravenous low-dose endotoxin (0.8 ng/kg) or placebo to 11 healthy subjects who had received oral pre-treatment with citalopram (10 mg twice a day) or placebo for 5 days. The Montgomery-Åsberg Depression Rating Scale, the State and Trait Anxiety Inventory, and a visual analog scale were used to measure depressive and anxiety symptoms and social anhedonia. Serum levels of TNF and IL-6 were measured with immunoassays. Compared to placebo, endotoxin administration increased serum levels of TNF and IL-6, and caused mild depressive-like symptoms, in particular lassitude and social anhedonia. While citalopram pre-treatment had no effect on the innate immune response to endotoxin, it reduced the endotoxin-induced MADRS total score by 50%, with a moderate effect size (Cohen's d=0.5). Most of the MADRS total score was due to the lassitude item, and citalopram pre-treatment specifically reduced endotoxin-induced lassitude with a large effect size (Cohen's d=0.9). These results suggest that subchronic pre-treatment with the serotonin-reuptake inhibitor citalopram blunts mood symptoms induced by acute immune system activation with endotoxin without inhibiting the peripheral immune response.

Indexed as

AdultAnxietyBehaviorCitalopramCytokinesDepressionDouble-Blind MethodEndotoxinsFatigueFemaleHumansInterpersonal RelationsMalePsychiatric Status Rating ScalesSelective Serotonin Reuptake InhibitorsSocial BehaviorCitalopramCytokinesEndotoxinsSelective Serotonin Reuptake Inhibitors

Identifiers

PMID20955776
PMCPMC3025065
OpenAlexW1972187375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.